Last 7 days
-0.6%
Last 30 days
1.3%
Last 90 days
13.7%
Trailing 12 Months
-12.9%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 40.4B | 6.8B | -13.31% | 3.22% | 32.19 | 5.89 | 8.37% | 3.64% |
ILMN | 35.5B | 4.6B | 5.65% | -27.02% | -8.07 | 7.75 | 1.28% | -677.95% |
MTD | 32.5B | 3.9B | -7.42% | 9.05% | 37.3 | 8.3 | 5.43% | 13.46% |
WAT | 18.2B | 3.0B | -10.97% | -4.88% | 25.66 | 6.11 | 6.68% | 2.15% |
PKI | 15.9B | 3.3B | -11.65% | -27.44% | 27.98 | 4.81 | -34.64% | -39.65% |
MID-CAP | ||||||||
SMALL-CAP | ||||||||
PACB | 2.0B | 128.3M | -11.70% | -1.09% | -6.37 | 15.61 | -1.69% | -73.40% |
ADPT | 1.2B | 185.3M | -5.41% | -23.53% | -6 | 6.49 | 20.06% | 3.42% |
QTRX | 450.3M | 105.5M | -12.44% | -50.56% | -4.66 | 4.27 | -4.55% | -67.63% |
NSTG | 405.5M | 127.3M | -23.43% | -69.17% | -2.54 | 3.19 | -12.28% | -38.43% |
BNGO | 341.8M | 27.8M | -23.57% | -31.43% | -2.58 | 12.29 | 54.62% | -83.06% |
CDXS | 271.1M | 138.6M | -29.13% | -76.08% | -8.07 | 1.96 | 32.30% | -57.86% |
PSNL | 135.5M | 65.0M | -20.46% | -63.49% | -1.2 | 2.08 | -23.92% | -73.73% |
HBIO | 117.4M | 113.3M | -15.92% | -55.18% | -12.34 | 1.04 | -4.68% | -3204.17% |
CSBR | 54.2M | 54.1M | -0.24% | -45.98% | 502.17 | 1 | 21.80% | -72.38% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -0.1% | 2,802,300,000 | 2,804,800,000 | 2,871,000,000 | 2,895,800,000 | 2,922,500,000 |
Gross Profit | -0.2% | 1,567,300,000 | 1,570,100,000 | 1,634,000,000 | 1,640,100,000 | 1,638,000,000 |
S&GA Expenses | -1.3% | 827,825,000 | 839,043,000 | 844,146,000 | 848,841,000 | 877,100,000 |
R&D Expenses | -0.6% | 256,889,000 | 258,342,000 | 252,874,000 | 249,231,000 | 260,600,000 |
EBITDA | 40.2% | -4,666,186,000 | -7,803,373,000 | -2,594,173,000 | -224,902,000 | 5,439,651,000 |
EBITDA Margin | 40.1% | -1.67 | -2.78 | -0.08 | 1.86 | - |
Earnings Before Taxes | 39.9% | -4,704,300,000 | -7,830,168,000 | -2,598,800,000 | -219,100,000 | 5,449,100,000 |
EBT Margin | 39.9% | -1.68 | -2.79 | -0.08 | 1.86 | - |
Interest Expenses | 42.2% | 38,114,000 | 26,795,000 | 15,558,000 | 5,201,000 | 1,551,000 |
Net Income | 39.8% | -3,627,500,000 | -6,027,400,000 | -1,935,000,000 | -93,100,000 | 4,254,200,000 |
Net Income Margin | 39.8% | -1.29 | -2.15 | -0.03 | 1.45 | - |
Free Cahsflow | -46.1% | 81,665,000 | 151,523,000 | 363,791,000 | 459,081,000 | 535,718,000 |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 12.0% | 13,502 | 12,058 | 12,682 | 14,374 | 17,799 |
Current Assets | 0.6% | 3,158 | 3,140 | 3,250 | 3,303 | 1,990 |
Cash Equivalents | -16.2% | 434 | 518 | 597 | 802 | 471 |
Inventory | 4.9% | 719 | 686 | 657 | 605 | 572 |
Net PPE | -2.5% | 499 | 512 | - | - | - |
Goodwill | 1.7% | 407 | 400 | 347 | 346 | 347 |
Liabilities | 7.8% | 3,886 | 3,605 | 3,760 | 4,191 | 4,114 |
Current Liabilities | -0.3% | 569 | 571 | 614 | 648 | 681 |
Long Term Debt | 11291.6% | 1,198 | 11.00 | - | - | - |
LT Debt, Non Current | 0.0% | 1,197 | 1,197 | 1,197 | 11.00 | - |
Shareholder's Equity | 13.7% | 9,615 | 8,454 | 8,923 | 10,183 | 13,685 |
Retained Earnings | 9.4% | 9,898 | 9,047 | 9,210 | 10,138 | 13,525 |
Additional Paid-In Capital | 3.9% | 447 | 431 | 472 | 459 | 442 |
Accumulated Depreciation | 0.8% | 1,009 | 1,002 | - | - | - |
Shares Outstanding | -0.2% | 30.00 | 30.00 | 30.00 | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -29.3% | 194 | 275 | 498 | 602 | 670 |
Cashflow From Investing | 29.2% | -1,207 | -1,705 | -1,702 | -1,661 | -797 |
Cashflow From Financing | -8.6% | 974 | 1,065 | 1,058 | 1,182 | -55.43 |
Buy Backs | 72.5% | 216 | 125 | 125 | 0.00 | 50.00 |
58.5%
34.6%
15.4%
Y-axis is the maximum loss one would have experienced if Bio Rad Laboratories was unfortunately bought at previous high price.
14.5%
20.0%
12.7%
11.2%
FIve years rolling returns for Bio Rad Laboratories.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | MATHER GROUP, LLC. | new | - | 217,393 | 217,393 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 35.51 | 1,202,530 | 4,484,530 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -8.34 | -23,000 | 276,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -2.73 | -64,841 | 3,225,160 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | new | - | 2,943 | 2,943 | -% |
2023-02-24 | National Pension Service | unchanged | - | 4,944 | 923,817 | -% |
2023-02-24 | NATIXIS | reduced | -29.68 | -172,612 | 418,388 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 102,000 | 12,874,000 | 0.14% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 39.32 | 19,116 | 68,116 | -% |
2023-02-21 | MACQUARIE GROUP LTD | unchanged | - | 6,943 | 946,943 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.66% | 2,391,436 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 6.4% | 1,582,313 | SC 13G/A | |
Apr 11, 2022 | schwartz alice n | 89.7% | 4,555,452 | SC 13D/A | |
Feb 09, 2022 | vanguard group inc | 9.21% | 2,287,465 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.1% | 1,768,081 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 9.18% | 2,272,373 | SC 13G/A | |
Feb 08, 2021 | fmr llc | - | 0 | SC 13G | |
Jan 29, 2021 | blackrock inc. | 7.6% | 1,892,336 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 234.47 -51.98% | 269.94 -44.72% | 384.70 -21.21% | 469.38 -3.87% | 567.20 16.16% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 08, 2023 | 4 | Insider Trading | |
Feb 23, 2023 | 8-K | Current Report | |
Feb 17, 2023 | 10-K | Annual Report | |
Feb 16, 2023 | 8-K | Current Report | |
Feb 14, 2023 | 4 | Insider Trading | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 01, 2023 | SC 13G/A | Major Ownership Report | |
Jan 10, 2023 | 8-K | Current Report | |
Dec 19, 2022 | 4 | Insider Trading |
Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||||||||||
Net sales | $ 730,300 | $ 680,800 | $ 691,100 | $ 700,100 | $ 732,800 | $ 747,000 | $ 715,900 | $ 726,800 | $ 2,802,249 | $ 2,922,545 | $ 2,545,626 |
Cost of Goods and Services Sold | 1,234,919 | 1,284,449 | 1,107,739 | ||||||||
Gross Profit | 397,100 | 372,600 | 395,000 | 402,600 | 399,900 | 436,500 | 401,100 | 400,500 | 1,567,330 | 1,638,096 | 1,437,887 |
Selling, general and administrative expense | 827,825 | 877,122 | 798,798 | ||||||||
Research and development expense | 256,889 | 260,638 | 217,763 | ||||||||
Income from operations | 482,616 | 500,336 | 421,326 | ||||||||
Interest expense | 38,114 | 1,551 | 21,861 | ||||||||
Foreign exchange losses, net | (205) | 2,753 | 1,771 | ||||||||
Debt and Equity Securities, Unrealized Gain (Loss) | 5,193,554 | (4,926,248) | (4,495,825) | ||||||||
Other (income) expense, net | (44,574) | (26,775) | (24,488) | ||||||||
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (4,704,273) | 5,449,055 | 4,918,007 | ||||||||
Income Tax Expense (Benefit) | 1,076,738 | (1,194,798) | (1,103,778) | ||||||||
Net Income (Loss) Attributable to Parent | $ 827,700 | $ (162,800) | $ (925,100) | $ (3,367,300) | $ (1,572,200) | $ 3,929,600 | $ 916,800 | $ 980,000 | $ (3,627,535) | $ 4,254,257 | $ 3,814,229 |
Basic earnings per share: | |||||||||||
Earnings Per Share, Basic | $ 27.89 | $ (5.48) | $ (31.05) | $ (112.5) | $ (52.54) | $ 131.80 | $ 30.80 | $ 32.86 | $ (121.79) | $ 142.61 | $ 128.13 |
Weighted average common shares - basic | 29,785 | 29,831 | 29,768 | ||||||||
Diluted earnings per share: | |||||||||||
Earnings Per Share, Diluted | $ 27.78 | $ (5.48) | $ (31.05) | $ (112.5) | $ (52.54) | $ 130.02 | $ 30.41 | $ 32.46 | $ (121.79) | $ 140.83 | $ 126.47 |
Weighted average common shares - diluted | 29,785 | 30,208 | 30,160 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
ASSETS: | ||
Cash and cash equivalents | $ 434,215 | $ 470,783 |
Short-term investments | 1,356,457 | 399,135 |
Restricted investments | 5,560 | 5,560 |
Accounts receivable, less allowance for doubtful accounts | 494,645 | 423,537 |
Inventories: | ||
Total inventories | 719,316 | 572,239 |
Prepaid expenses | 124,179 | 109,136 |
Other current assets | 23,604 | 10,089 |
Total current assets | 3,157,976 | 1,990,479 |
Property, plant and equipment: | ||
Land and improvements | 27,805 | 27,940 |
Buildings and leasehold improvements | 393,620 | 385,798 |
Equipment | 1,086,595 | 1,099,741 |
Total property, plant and equipment | 1,508,020 | 1,513,479 |
Less: accumulated depreciation and amortization | (1,009,408) | (1,001,840) |
Property, plant and equipment, net | 498,612 | 511,639 |
Operating Lease, Right-of-Use Asset | 180,952 | 204,798 |
Goodwill | 406,488 | 347,343 |
Intangible Assets, Net (Excluding Goodwill) | 332,147 | 253,939 |
Other investments | 8,830,892 | 14,387,006 |
Other assets | 94,599 | 104,189 |
Total assets | 13,501,666 | 17,799,393 |
LIABILITIES AND STOCKHOLDERS' EQUITY: | ||
Accounts payable | 135,041 | 141,941 |
Accrued payroll and employee benefits | 194,790 | 276,986 |
Current maturities of long-term debt | 465 | 489 |
Income taxes payable | 11,929 | 10,319 |
Accrual for Taxes Other than Income Taxes, Current | 20,499 | 35,980 |
Current operating lease liabilities | 36,336 | 36,435 |
Deferred revenue | 52,211 | 50,852 |
Other current liabilities | 117,437 | 127,936 |
Total current liabilities | 568,708 | 680,938 |
Long-term debt, net of current maturities | 1,197,716 | 10,514 |
Deferred Income Tax Liabilities, Net | 1,770,481 | 3,064,576 |
Operating lease liabilities | 153,597 | 175,938 |
Other long-term liabilities | 195,912 | 182,191 |
Total liabilities | 3,886,414 | 4,114,157 |
Commitments and contingent liabilities | ||
Stockholders' equity: | ||
Preferred stock | 0 | 0 |
Additional paid-in capital | 447,454 | 441,733 |
Retained earnings | 9,898,203 | 13,525,343 |
Accumulated other comprehensive (loss) income | (466,822) | (175,553) |
Stockholders' Equity Attributable to Parent | 9,615,252 | 13,685,236 |
Total liabilities and stockholders' equity | 13,501,666 | 17,799,393 |
Common Class A [Member] | ||
Stockholders' equity: | ||
Common stock | 2 | 2 |
Common Class B [Member] | ||
Stockholders' equity: | ||
Common stock | 1 | 1 |
Treasury Class-A [Member] | ||
Stockholders' equity: | ||
Treasury Stock, Value | $ (263,586) | $ (106,290) |